Venus Remedies awarded its first incentive of Rs.7.50 cr. under PLI scheme
Venus Remedies Ltd, one of India’s leading manufacturers of generic drugs, has been awarded its first disbursement of Rs 7.5 crore under the Central government’s Production Linked Incentive (PLI) scheme for the financial year 2022-23, which covers 75% of the…
Venus Remedies gets coveted GMP certification from Libya
Venus Remedies, a globally recognised pharmaceutical company, has been awarded the Good Manufacturing Practices (GMP) certification for its facilities from the Ministry of Health, Libya. This accomplishment is a testament to the company’s commitment to quality, safety and efficiency in…
Venus Remedies gets coveted GMP certification from Libya
Venus Remedies, a globally recognised pharmaceutical company, has been awarded the Good Manufacturing Practices (GMP) certification for its facilities from the Ministry of Health, Libya. This accomplishment is a testament to the company’s commitment to quality, safety and efficiency in…
Venus Remedies expands global presence with marketing authorisation for enoxaparin from Azerbaijan
Venus Remedies Limited, a leading fixed-dosage injectable manufacturer, has reached a significant milestone with a marketing authorisation from Azerbaijan for the first time for enoxaparin, an anticoagulant that plays a crucial role in addressing blood clot formation in patients suffering…
Venus Remedies on expansion spree in Gulf, gets Saudi marketing approval for Enoxaparin in PFS
Making rapid global strides by expanding its reach in the Gulf, Venus Remedies Ltd, a leading exporter of affordable generic drugs with presence in more than 80 countries, has received marketing approval from Saudi Arabia, the largest pharmaceutical market in…
